Boussageon, Rémy

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., & Cornu, C. (2011) · BMJ

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 803

Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials

Boussageon, R., Supper, I., Bejan-Angoulvant, T., Kellou, N., Cucherat, M., Boissel, J.-P., Kassai, B., Moreau, A., Gueyffier, F., & Cornu, C. (2012) · PLoS Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 266

Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate

Palpacuer, C., Duprez, R., Huneau, A., Locher, C., Boussageon, R., Laviolle, B., & Naudet, F. (2018) · Addiction

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 172

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials

Palpacuer, C., Laviolle, B., Boussageon, R., Reymann, J. M., Bellissant, E., & Naudet, F. (2015) · PLOS Medicine

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 102

How do they add up? The interaction between the placebo and treatment effect: A systematic review

Boussageon, R., Howick, J., Baron, R., Naudet, F., Falissard, B., Harika‐Germaneau, G., Wassouf, I., Gueyffier, F., Jaafari, N., & Blanchard, C. (2022) · British Journal of Clinical Pharmacology

Pain Management and Placebo EffectStatistical Methods in Clinical Trials

Cited by 36

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: a meta-regression analysis

Grenet, G., Le, H. H., Bejan-Angoulvant, T., Erpeldinger, S., Boussageon, R., Kassaï, B., Moulin, P., Gueyffier, F., & Cucherat, M. (2019) · Diabetes & Metabolism

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 6